Equity and Stock-Based Compensation | Equity and Stock-Based Compensation Equity Transactions During the thirty-nine weeks ended September 24, 2023, funds managed by the Company’s majority owner, Advent International Corporation, (“Advent”) sold 3,500,000 and 3,000,000 shares of the Company’s common stock through underwritten secondary public offerings that were completed on May 18, 2023 and June 13, 2023, respectively. The selling stockholders sold an additional 525,000 and 450,000 shares of common stock on May 18, 2023 and July 3, 2023, respectively, pursuant to the terms of the underwriter’s option associated with each secondary public offering. All net proceeds from the sale of the shares of common stock were distributed to the selling stockholders. The Company incurred approximately $1.0 million of costs in connection with the offerings that were recorded within Transaction expenses, net on the Consolidated Statements of Operations and Comprehensive Income. During the thirteen weeks ended September 25, 2022, funds managed by Advent, sold 4,500,000 shares of the Company’s common stock through a secondary public offering that was completed on September 19, 2022. The selling stockholders sold an additional 675,000 shares of common stock on October 6, 2022 pursuant to the terms of the underwriters option associated with the secondary offering. All net proceeds from the sale of the shares of common stock were distributed to the selling stockholders. The Company incurred approximately $1.6 million of costs in connection with the offerings that were recorded within Transaction expenses, net on the Consolidated Statements of Operations and Comprehensive Income. Stock option awards There were no stock option awards granted under the 2021 Equity Plan during the thirty-nine weeks ended September 24, 2023. A summary of stock option activity during the thirty-nine weeks ended September 24, 2023 is as follows: NUMBER OF OPTIONS WEIGHTED AVERAGE AGGREGATE INTRINSIC VALUE (in thousands) WEIGHTED AVERAGE REMAINING CONTRACTUAL LIFE (in years) Outstanding, December 25, 2022 5,115,674 $ 10.12 $ 20,981 6.1 Exercised (545,669) $ 9.18 Forfeited (126,113) $ 12.12 Outstanding, September 24, 2023 4,443,892 $ 10.18 $ 34,316 5.4 Exercisable, September 24, 2023 2,706,341 $ 9.67 $ 22,277 4.9 The aggregate intrinsic value is based on the difference between the exercise price of the stock option and the closing price of the Company’s common stock on Nasdaq on the last trading day. A summary of the non-vested stock option activity during the thirty-nine weeks ended September 24, 2023 is as follows: NUMBER OF OPTIONS WEIGHTED AVERAGE GRANT DATE FAIR VALUE Nonvested, December 25, 2022 2,324,316 $ 7.31 Vested (460,652) $ 5.59 Forfeited (126,113) $ 6.47 Nonvested, September 24, 2023 1,737,551 $ 7.83 Restricted stock units A summary of activity for restricted stock units during the thirty-nine weeks ended September 24, 2023 is as follows: RESTRICTED STOCK UNITS WEIGHTED AVERAGE AGGREGATE INTRINSIC VALUE (in thousands) Outstanding, December 25, 2022 38,311 $ 14.36 $ 544 Granted 538,007 $ 15.67 Vested (38,311) $ 14.36 Forfeited (22,228) $ 15.52 Outstanding, September 24, 2023 515,779 $ 15.67 $ 9,232 The aggregate intrinsic value is based on the closing price of the Company’s common stock on Nasdaq of $17.90 and $14.21 on September 22, 2023 and December 23, 2022, the last trading days for the periods, respectively. Stock-based compensation expense was $1.8 million and $5.4 million during the thirteen and thirty-nine weeks ended September 24, 2023, respectively. Stock-based compensation expense was $2.7 million and $7.8 million during the thirteen and thirty-nine weeks ended September 25, 2022, respectively. The total related income tax benefit for stock-based compensation expense was $0.8 million and $1.3 million during the thirteen and thirty-nine weeks ended September 24, 2023, respectively. The total related income tax benefit for stock-based compensation expense was less than $0.1 million during the thirteen and thirty-nine weeks ended September 25, 2022. Unrecognized stock-based compensation expense The following represents unrecognized stock-based compensation expense and the remaining weighted average vesting period as of September 24, 2023: UNRECOGNIZED STOCK-BASED COMPENSATION EXPENSE (in thousands) REMAINING WEIGHTED AVERAGE VESTING PERIOD (in years) Stock options $ 4,574 0.8 Restricted stock units $ 6,549 2.4 |